Novel α-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease

Experimental Neurology

Volumn 154, Issue 2, 1998, Pages 684-690

  Langston, J William ^a   Sastry, Savitha ^a   Chan, Piu ^a   Forno, Lysia S ^b   Bolin, Laurel M ^a   Di Monte, Donato A ^a  

^a PARKINSON S INSTITUTE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Lewy body; Neurodegeneration; Parkinson's disease; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; BRAIN HOMOGENATE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FRONTAL CORTEX; GENE MUTATION; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SUBSTANTIA NIGRA;

EID: 0032425283     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6975     Document Type: Article

References (18)

1. Baba M., Nakajo S., Tu P. H., Tomita T., Nakaya K., Lee V. M., Trojanowski J. Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884.
2. Chan P., Tanner C. M., Jiang X., Langston J. W. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology. 50:1998;513-514.
3. Chan P., Jiang X., Forno L. S., Di Monte D. A., Tanner C. M., Langston J. W. Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease. Neurology. 50:1998;1136-1137.
4. Davidson W. S., Jonas A., Clayton D. F., George J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273:1998;9443-9449.
5. Gai W. P., Power J. H., Blumbergs P. C., Blessing W. W. Multiple-system atrophy: A new alpha-synuclein disease. Lancet. 352:1998;547-548.
6. Golbe L. I., Di Iorio G., Sanges G., Lazzarini A. M., Sala S. L., Bonavita V., Duuviosin R. C. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann. Neurol. 40:1996;767-775.
7. Han H., Weinreb P. H., Lansbury P. T. Jr. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease. Chem. Biol. 2:1995;163-169.
8. Irizarry M. C., Growdon W., Gomez-Isla T., Newell K., George J. M., Clayton D. F., Hyman B. T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57:1998;334-337.
9. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genet. 18:1998;106-108.
10. Paik S. R., Lee J. H., Kim D. H., Chang C. S., Kim Y. S. Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35). FEBS Lett. 421:1998;73-76.
11. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
12. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
13. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA. 95:1998;6469-6473.
14. Trojanowski J. Q., Lee V. M. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55:1998;151-152.
15. Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J. Q., Lee V. M. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44:1998;415-422.
16. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;11282-11286.
17. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239:1997;45-48.
18. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249:1998;180-182.